Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature

Lipophilic but not hydrophilic statins have been shown to be associated with reduced risk for hepatocellular carcinoma (HCC) in patients with chronic viral hepatitis. We investigated differential actions of lipophilic and hydrophilic statins and their ability to modulate a clinical prognostic liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Myung‐Ho, Kim, Mi‐Young, Salloum, Shadi, Qian, Tongqi, Wong, Lai Ping, Xu, Min, Lee, Yoojin, Shroff, Stuti G., Sadreyev, Ruslan I., Corey, Kathleen E., Baumert, Thomas F., Hoshida, Yujin, Chung, Raymond T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426409/
https://www.ncbi.nlm.nih.gov/pubmed/35712812
http://dx.doi.org/10.1002/hep4.1991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426409/
https://www.ncbi.nlm.nih.gov/pubmed/35712812
http://dx.doi.org/10.1002/hep4.1991

Ejemplares similares